August 2016

Important New Products

• Fraxiparine (nadroparin calcium) is a low molecular weight heparin made by...(more)
• Herceptin SC (trastuzumab (rch)) is a recombinant DNA derived humanized monoclonal ...(more)
• Lonquex (lipegfilgrastim (rbe)) is a long acting form of recombinant human granulocyte ...(more)
• Sylvant (siltuximab) is a chimeric (human murine) immunoglobulin G1k (IgG1k) monoclonal ...(more)

Safety Related Changes

• Eviplera (300 mg tenofovir disoproxil fumarate/200 mg emtricitabine/25 mg rilpivirine) ...(more)
• Humira (adalimumab (rch)) is now indicated for the treatment of active moderate to severe ...(more)
• Nolvadex (tamoxifen citrate) is now indicated for the primary reduction of breast cancer ...(more)
• Revlimid (lenalidomide) is now indicated for the treatment of patients with relapsed ...(more)

Active Ingredient Naming Changes

In this release, MIMS Australia will be including the following INNs (International Non-proprietary Names) as well as Australian Approved Names (AANs) as part of our push to support the Therapeutic Goods Administration (TGA) active ingredient name changes project.  

MIMS will begin referring to these ingredients by their new names, however, users may continue to search by the old AANs if preferred. 

Deleted Products

• Antistine-Privine 
• APO-Trandolapril 
• Chemmart Gemfibrozil 
• Chemmart Olanzapine ODT 
• GenRx Gemfibrozil 
• Merrem I.V. 
• Terry White Chemists Gemfibrozil 
• Terry White Chemists Olanzapine ODT

To contact MIMS editorial please email To enquire about purchasing a product please contact MIMS Customer service on 1800 800 629 or email For more information about MIMS, please see

Copyright © 2016 MIMS Australia Pty Ltd. All rights reserved.
Our mailing address is:
MIMS Australia, Level 2, 1 Chandos Street, St Leonards NSW 2065, Phone: 1800 800 629